Cargando…
Longitudinal Study of Informed Consent in Innovative Therapy Research: Experience and Provisional Recommendations from a Multicenter Trial of Intracerebral Grafting
BACKGROUND: There is an urgent need to assess and improve the consent process in clinical trials of innovative therapies for neurodegenerative disorders. METHODS: We performed a longitudinal study of the consent of Huntington’s disease patients during the Multicenter Fetal Cell Intracerebral Graftin...
Autores principales: | Cleret de Langavant, Laurent, Sudraud, Sophie, Verny, Christophe, Krystkowiak, Pierre, Simonin, Clémence, Damier, Philippe, Demonet, Jean-François, Supiot, Frédéric, Rialland, Amandine, Schmitz, David, Maison, Patrick, Youssov, Katia, Bachoud-Lévi, Anne-Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444138/ https://www.ncbi.nlm.nih.gov/pubmed/26010368 http://dx.doi.org/10.1371/journal.pone.0128209 |
Ejemplares similares
-
How to Capitalize on the Retest Effect in Future Trials on Huntington’s Disease
por: Schramm, Catherine, et al.
Publicado: (2015) -
Effectiveness of Anti-Psychotics and Related Drugs in the Huntington French-Speaking Group Cohort
por: Désaméricq, Gaëlle, et al.
Publicado: (2014) -
COMT Val(158)Met Polymorphism Modulates Huntington's Disease Progression
por: de Diego-Balaguer, Ruth, et al.
Publicado: (2016) -
Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington’s Disease
por: Salem, Linda, et al.
Publicado: (2016) -
Self-Reported Social Relationship Capacities Predict Motor, Functional and Cognitive Decline in Huntington’s Disease
por: Lemercier, Pablo, et al.
Publicado: (2022)